Company intelligence / Profile preview
Changshu Leiyunshang Pharmaceutical
- Ownership
- Private
- Development stage
- Other
Overview
Changshu Leiyunshang Pharmaceutical specializes in the research, development, manufacturing, and commercialization of traditional Chinese medicines—especially injections and oral liquids. The company has GMP-certified facilities with advanced extraction/refining systems. It focuses on liver disease therapies but also develops products for cardiovascular/cerebrovascular conditions and oncology support. The company has received national recognition as a high-tech enterprise. Clinical results are not detailed publicly but the group emphasizes multi-center clinical studies to validate efficacy. Pipeline breadth includes multiple marketed products plus ongoing innovation projects.
- Therapeutic areas
- Metabolic DisordersGastroenterologyOncologyCardiovascular
- Modalities
- Small molecule (traditional Chinese medicine injections and oral liquids)Biologic (herbal/botanical drugs)Traditional Chinese medicine preparation
- Industry
- Biotech
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Changshu Leiyunshang Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Changshu Leiyunshang Pharmaceutical.